MN rgp120/HIV-1 and GNE8 rgp120/HIV-1 [clinicaltrials_resource:0e545071483d94361d54bf164b37e854]
A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers [clinicaltrials:NCT00000871]A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers [clinicaltrials:NCT00000879]A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines [clinicaltrials:NCT00002402]Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection [clinicaltrials:NCT00002441]Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B [clinicaltrials:NCT00007332]
intervention [clinicaltrials_vocabulary:intervention]
MN rgp120/HIV-1 and GNE8 rgp120/HIV-1 [clinicaltrials_resource:0e545071483d94361d54bf164b37e854]
Bio2RDF identifier
0e545071483d94361d54bf164b37e854
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0e545071483d94361d54bf164b37e854
intervention name [clinicaltrials_vocabulary:intervention-name]
MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
identifier
clinicaltrials_resource:0e545071483d94361d54bf164b37e854
title
MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
@en
type
label
MN rgp120/HIV-1 and GNE8 rgp12 ...... 45071483d94361d54bf164b37e854]
@en